WBA 📈 Walgreens Boots Alliance - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9314271084

WBA: Pharmacy, Health, Wellness, Beauty, Personal Care, General Merchandise

Walgreens Boots Alliance Inc is a leading healthcare, pharmacy, and retail company with a global presence, operating in the United States, the United Kingdom, Germany, and other international markets.

The company's U.S. Retail Pharmacy segment is a dominant player in the retail drugstore space, offering a wide range of health and wellness services, specialty pharmacy services, and home delivery options. Its stores provide customers with a convenient and accessible way to purchase health and wellness products, beauty and personal care items, consumables, and general merchandise.

The International segment is a significant contributor to the company's revenue, with a strong presence in the United Kingdom, the Republic of Ireland, and Thailand through its Boots brand stores. Additionally, the company operates under the Benavides brand in Mexico and the Ahumada brand in Chile, offering a diverse range of prescription drugs, health and wellness products, and consumer goods.

The U.S. Healthcare segment is a key growth driver for the company, providing value-based care services through its VillageMD platform. This platform offers primary, multi-specialty, and urgent care services to patients in traditional clinic settings, as well as in-home and online appointments. The segment also includes Shields, a specialty pharmacy integrator and accelerator for hospitals, and CareCentrix, a participant in the post-acute and home care management sectors.

With a rich history dating back to 1909, Walgreens Boots Alliance Inc is headquartered in Deerfield, Illinois, and has established itself as a trusted and reliable partner in the healthcare and retail industries. For more information, visit the company's website at https://www.walgreensbootsalliance.com.

Additional Sources for WBA Stock

WBA Stock Overview

Market Cap in USD 7,332m
Sector Healthcare
Industry Pharmaceutical Retailers
GiC Industry Consumer Staples Distribution & Retail
TER 0.00%
IPO / Inception 1985-07-01

WBA Stock Ratings

Growth 5y -91.9%
Fundamental -44.3%
Dividend 63.5%
Rel. Performance Sector -9.31
Analysts 2.89/5
Fair Price Momentum 7.03 USD
Fair Price DCF -

WBA Dividends

Dividend Yield 12m 11.14%
Yield on Cost 5y 2.23%
Annual Growth 5y 1.36%
Payout Consistency 97.72%

WBA Growth Ratios

Growth Correlation 3m 32.8%
Growth Correlation 12m -96%
Growth Correlation 5y -74.9%
CAGR 5y -27.49%
CAGR/Mean DD 5y -0.82
Sharpe Ratio 12m -1.36
Alpha -78.34
Beta 0.70
Volatility 54.53%
Current Volume 18339.8k
Average Volume 20d 19812.2k
What is the price of WBA stocks?
As of December 03, 2024, the stock is trading at USD 8.98 with a total of 18,339,773 shares traded.
Over the past week, the price has changed by -0.88%, over one month by -0.83%, over three months by +3.15% and over the past year by -53.27%.
Is Walgreens Boots Alliance a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Walgreens Boots Alliance (NASDAQ:WBA) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.25 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WBA as of December 2024 is 7.03. This means that WBA is currently overvalued and has a potential downside of -21.71%.
Is WBA a buy, sell or hold?
Walgreens Boots Alliance has received a consensus analysts rating of 2.89. Therefor, it is recommend to hold WBA.
  • Strong Buy: 1
  • Buy: 2
  • Hold: 12
  • Sell: 2
  • Strong Sell: 2
What are the forecast for WBA stock price target?
According to ValueRays Forecast Model, WBA Walgreens Boots Alliance will be worth about 7.6 in December 2025. The stock is currently trading at 8.98. This means that the stock has a potential downside of -15.48%.
Issuer Forecast Upside
Wallstreet Target Price 10.8 20.7%
Analysts Target Price 26.1 190.8%
ValueRay Target Price 7.6 -15.5%